Novo Integrated Sciences Shares Outstanding 2012-2024 | NVOS

Novo Integrated Sciences shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Novo Integrated Sciences Annual Shares Outstanding
(Millions of Shares)
2023 10
2022 3
2021 2
2020 2
2019 22
2018 21
2017 18
2016 2
2016 17
2015 2
2014 2
2013 15
2012 7
2012
2011 5
2011
Novo Integrated Sciences Quarterly Shares Outstanding
(Millions of Shares)
2024-02-29 18
2023-11-30 17
2023-08-31 10
2023-05-31 14
2023-02-28 8
2022-11-30 3
2022-08-31 3
2022-05-31 3
2022-02-28 3
2021-11-30 3
2021-08-31 2
2021-05-31 3
2021-02-28 2
2020-11-30 2
2020-08-31 2
2020-05-31 2
2020-02-29 2
2019-11-30 22
2019-08-31 22
2019-05-31 22
2019-02-28 21
2018-11-30 21
2018-08-31 21
2018-05-31 21
2018-02-28 21
2017-11-30 20
2017-08-31 18
2017-05-31 17
2017-03-31 2
2017-02-28 17
2016-12-31
2016-11-30 17
2016-09-30 2
2016-06-30 2
2016-05-31 17
2016-03-31 2
2015-12-31
2015-09-30 2
2015-06-30 2
2015-03-31 2
2014-12-31
2014-09-30 2
2014-06-30 2
2014-03-31 27
2013-12-31
2013-09-30 18
2013-06-30 10
2013-03-31 7
2012-12-31
2012-09-30 7
2012-08-31
2012-06-30 7
2012-03-31 6
2012-02-29
2011-12-31
2011-11-30
2011-09-30 5
2011-08-31
2011-06-30 5
2011-05-31
2011-03-31 5
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.010B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.26
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
U.S Physical Therapy (USPH) United States $1.516B 39.30
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00